Factors associated with oxygen requirement and persistent symptoms 1 year after severe COVID-19 infection

Serrano, María Natalia; Velandía, Oscar Mauricio Muñoz; Rueda, Camilo; Arboleda, Alejandra Cañas; Botero, J.; Bustos, Marlon Mauricio

doi:10.1177/03000605231173317

Cited by 2 publications

(1 citation statement)

References 23 publications

(31 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Colombia, there have been two published reports on the presentation of post-COVID-19 conditions. Compared to these data, the obtained prevalence rate of dyspnea was more similar to that reported by Serrano et al, in which 31% of patients experienced dyspnea one year after ICU discharge (21). Anaya et al found a lower rate of this symptom in a sample of 100 patients with an antecedent of SARS-CoV-2 infection (22).…”

Section: Discussionsupporting

confidence: 85%

Prevalence of post-COVID symptoms in a cohort of hospitalized patients in the North Coast of Colombia

Lozano,

Salcedo-Mejia,

Dueñas

et al. 2024

Preprint

View full text Add to dashboard Cite

Understanding the prevalence and severity of post-COVID-19 conditions among hospitalized patients is crucial for developing effective strategies for managing the long-term consequences of the disease. This study aimed to estimate the prevalence and severity of post-COVID-19 conditions in previously hospitalized COVID-19 patients. The study involved two phases: first, participants were contacted via phone call by trained personnel from the healthcare company and surveyed. In the second phase, two months after the telephone survey, a medical visit was conducted in the group of individuals who reported persistent symptoms in the previous call. Summary statistics such as mean, standard deviation (SD), interquartile range (IQR), 95%CI as well as absolute and relative frequencies of patients' baseline characteristics were reported. Changes were assessed through statistical tests for differences in means and proportions. Multivariate analyses were also conducted. The prevalence of at least one post-hospitalization condition after three months of COVID-19 hospitalization was 78.7 per 100 people. The most common symptoms included fatigue (55.4%), joint pain (46.0%), dyspnea (44.6%), sleep disorders (36.1%), anorexia (33.7%), and chest pain (31.7%). These conditions were frequent and disabling, experiencing at least one condition after three months. Within this group, more than 70% showed a deterioration in their health status (EQ5D-5L Scale) or experienced new or worsened disability in at least one domain of the Washington Group. Our study demonstrates that post-COVID-19 conditions in previously hospitalized patients are highly prevalent, which can adversely affect patients' quality of life and lead to increased demand for healthcare services.

show abstract

Section: Discussionsupporting

confidence: 85%

Prevalence of post-COVID symptoms in a cohort of hospitalized patients in the North Coast of Colombia

Lozano,

Salcedo-Mejia,

Dueñas

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

The relationship between the need for prolonged oxygen therapy after discharge in COVID-19 patients and mortality

Doğru,

Uyar,

Aytaç

et al. 2024

Journal of Health Sciences and Medicine

View full text Add to dashboard Cite

Aims: The COVID-19 pandemic has severely burdened healthcare systems worldwide due to the rapid rise in cases, often resulting in respiratory distress requiring oxygen therapy. However, research on the availability and long-term usage of oxygen concentrators upon discharge is limited. This study aimed to identify factors associated with the need for oxygen concentrators in discharged COVID-19 patients, as well as device acquisition and mortality rates. Methods: This study, conducted at a single center, comprised retrospective and prospective phases. Data were gathered from hospitalized COVID-19 patients, with follow-up conducted one year later for those prescribed oxygen concentrators at discharge. Sociodemographic and clinical variables were recorded, and statistical analyses were conducted to determine factors associated with oxygen concentrator need and duration of use. Results: Among 229 patients, 15.7% required oxygen concentrators at discharge. Factors associated with this need included older age, asthma, bilateral lung lesions, and the severity of lesions detected on thoracic computed tomography scans. Patients with corticosteroid use and hypertension required oxygen concentrators for over three months. Economic limitations impeded the acquisition of devices for 22.2% of patients who were prescribed them. Two to three months post-discharge, 72.2% of patients still used oxygen concentrators. Mortality analysis showed a 16.6% fatality rate among oxygen concentrator prescribed patients within one year, with shorter survival observed in those unable to obtain the device. Conclusion: This study highlights the significance of assessing factors impacting oxygen concentrator requirement in COVID-19 patients and their long-term prognosis. These findings should inform healthcare providers and policymakers in pandemic preparedness efforts, emphasizing tailored treatment approaches based on individual patient characteristics. Ensuring device accessibility and regular patient follow-up are crucial for optimizing healthcare delivery during similar crises.

show abstract

Factors associated with oxygen requirement and persistent symptoms 1 year after severe COVID-19 infection

Cited by 2 publications

References 23 publications

Prevalence of post-COVID symptoms in a cohort of hospitalized patients in the North Coast of Colombia

Prevalence of post-COVID symptoms in a cohort of hospitalized patients in the North Coast of Colombia

The relationship between the need for prolonged oxygen therapy after discharge in COVID-19 patients and mortality

Contact Info

Product

Resources

About